Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Pituitary Neoplasms 4 Nelson Syndrome 2 Multiple Myeloma 2 Carcinoma, Hepatocellular 2 Carcinoid Tumor 2 ACTH Syndrome, Ectopic 2 Uveal Melanoma 1 Thyroid Neoplasms 1 Small Cell Lung Carcinoma 1 Serotonin Syndrome 1 Sarcoma, Synovial 1 Prostatic Neoplasms 1 Prolactin-Producing Pituitary Tumor 1 Primary Inoperable Thymoma 1 Precursor Cell Lymphoblastic Leukemia-Lymphoma 1 Pituitary ACTH Hypersecretion 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Neuroendocrine Tumors 1 Neuroectodermal Tumors, Primitive 1 Neoplasms 1 Neoplasm Metastasis 1 Myelodysplastic Syndromes 1 Meningioma 1 Lymphoma 1 Liver Neoplasms 1 Leukemia, Myeloid, Acute 1 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1 Insulinoma 1 Hyperinsulinism 1

Interventions

Paclitaxel 12 Cisplatin 11 Hyperthermic Intraperitoneal Chemotherapy 10 Cytoreduction Surgical Procedures 9 Oxaliplatin 8 Fluorouracil 7 Mitomycin 6 Carboplatin 5 Leucovorin 4 Bevacizumab 4 catumaxomab 3 Doxorubicin 3 Docetaxel 3 sodium thiosulfate 2 Indocyanine Green 2 Drug Therapy 2 Cetuximab 2 volociximab 1 vandetanib 1 relacorilant 1 pasireotide 1 nilotinib 1 farletuzumab 1 epothilone B 1 enzastaurin 1 birinapant 1 alvimopan 1 Surgical Procedures, Operative 1 Saline Waters 1 Platinum 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Peritoneal Neoplasms × pasireotide × Clear all

NCT04826432 2024-02-08

PASIREOCHIP

Gustave Roussy, Cancer Campus, Grand Paris

Phase 2 Terminated

Peritoneal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡